Uncovering behind-the-scenes challenges in bringing gene therapies to market
Patients getting access to expensive gene therapies is just one of the many challenges to bringing these sometimes life-saving drugs to market.
Read MoreReducing the Unexpected and Unnecessary Costs of Musculoskeletal Condition Care
Musculoskeletal (MSK) injuries or disorders affect nearly half of U.S. adults1 and are one of the top health categories of plan sponsor spend at $420B. This topic was the focus of a breakout sessi...
Read MoreWhat Is Drug Trend and How to Manage it
Drug trend, a good annual barometer for plan sponsor who are looking to control traditional and specialty drug costs, can and should be managed to improve medication access. This topic was the foc...
Read MoreAntibiotic Resistance: A Threat to All Of Us
When germs no longer respond to antibiotics, the cost to our health and budgets is enormous
Read MoreWith the right formulary, plans can control drug costs while preserving access
Each plan determines which formulary is best for its unique circumstances.
Read More